1. A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus

Mohammad Mostafa Pourseif, Gholamali Moghaddam*, Hossein Daghighkia, Ahmad Nematollahi, Yadollah Omidi*

Bioimpacts. 2018;8(1): 39-52. doi: 10.15171/bi.2018.06

PMCID: PMC5915707 PMID: 29713601 Scopus ID: 85044310762

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Original Research

2. A multi-method and structure-based in silico vaccine designing against Echinococcus granulosus through investigating enolase protein

Mohammad Mostafa Pourseif, Mitra Yousefpour*, Mohammad Aminianfar, Gholamali Moghaddam, Ahmad Nematollahi

Bioimpacts. 2019;9(3): 131-144. doi: 10.15171/bi.2019.18

PMCID: PMC6726745 PMID: 31508329 Scopus ID: 85071191509

Article

PDF

Suppl 1

Full Text

XML

Cited By:

The minigene vaccine construct is designed based on the B and T cell epitopes of E. granulosus enolase protein, and ligands for TLR-2 and TLR-4. The minigene vaccine showed stable properties for proper binding with the Toll-like receptors.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons